Histone Deacetylase Inhibitor (HDACi) Conjugated Polycaprolactone for Combination Cancer Therapy

Ruvanthi N. Kularatne, Katherine E. Washington, Chandima Bulumulla, Erika L. Calubaquib, Michael C. Biewer, David Oupicky, Mihaela C. Stefan

Research output: Contribution to journalArticle

4 Scopus citations

    Fingerprint

ASJC Scopus subject areas

  • Bioengineering
  • Biomaterials
  • Polymers and Plastics
  • Materials Chemistry

Cite this

Kularatne, R. N., Washington, K. E., Bulumulla, C., Calubaquib, E. L., Biewer, M. C., Oupicky, D., & Stefan, M. C. (2018). Histone Deacetylase Inhibitor (HDACi) Conjugated Polycaprolactone for Combination Cancer Therapy. Biomacromolecules, 19(3), 1082-1089. https://doi.org/10.1021/acs.biomac.8b00221